Association of 5-HT, ET-1, PTX-3, and inflammatory markers with clinical parameters in pediatric migraine patients with patent foramen ovale

This publication has 42 references indexed in Scilit:

• Metabolomic Analysis of Patients With Patent Foramen Ovale and Migraine Using Liquid Chromatography‐Mass Spectrometry Technology
  Rapid Communications in Mass Spectrometry, 2025
• Association of in situ thrombus within the patent foramen ovale and patients with migraine: A prospective cohort study
  Heliyon, 2024
• Headache patterns in patent foramen ovale patients: beyond migraine with aura
  Journal of Neural Transmission, 2024
• Association between patent foramen ovale and migraine: evidence from a resting-state fMRI study
  Brain Imaging and Behavior, 2024
• Design, synthesis and biological evaluation of pyridinylmethylenepiperidine derivatives as potent 5-HT1F receptor agonists for migraine therapy
  European Journal of Medicinal Chemistry, 2021
• Pentraxin 3 level in acute migraine attack with aura: Patient management in the emergency department
  The American Journal of Emergency Medicine, 2020
• Is patent foramen ovale the culprit in women with migraine and cardiovascular disease?
  International Journal of Cardiology, 2006
• Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting
  American Heart Journal, 2006
• Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype
  The Journal of Headache and Pain, 2005
• High prevalence of patent foramen ovale in migraine with aura
  The Journal of Headache and Pain, 2005